|SEQ_NO||1||Date of announcement||2021/01/18||Time of announcement||17:02:26|
|Subject||Announcement of TTY Biopharm's unaudited income information in December 2020|
|Date of events||2021/01/18||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/01/18
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $373,446 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $79,250 thousands, and a consolidated income before tax of $74,498 thousands in December 2020; net income attributed to stockholders of the company was $56,343 thousands; EPS is $0.23.
Year-to-date consolidated net sales was $4,222,212 thousands (in NT dollars; unaudited), a consolidated operating profit was $957,864 thousands and consolidated income before tax was $1,115,825 thousands until December 2020; year-to-date net income attributed to stockholders of the company was $840,069 thousands; EPS is $3.38.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.